The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
, neuroinflammation, transcriptomic and proteomics, cell and animal model development, disease biomarkers and novel therapeutics. The successful candidate is expected to bring or develop an independent, nationally
-
proteomics, cell and animal model development, disease biomarkers and novel therapeutics. The successful candidate is expected to bring or develop an independent, nationally competitive research program that
-
understanding the cellular and molecular mechanisms underlying the formation and diversification of human NK cell repertoires in health and disease. A central aspect of these studies has been to examine the
-
Engineering has been at the forefront of innovation for nearly a century, creating pivotal technologies that have transformed the worlds of information technology, communications, health care, energy, business
-
, all influenced by Penn’s distinctive interdisciplinary approach to scholarship and learning. As an employer Penn has been ranked nationally on many occasions with the most recent award from Forbes who
-
of Wisconsin School of Medicine and Public Health. Of the 16 faculty, five affiliate faculty, and emeritus faculty, several have been recognized with national and international honors, including by the National
-
, all influenced by Penn’s distinctive interdisciplinary approach to scholarship and learning. As an employer Penn has been ranked nationally on many occasions with the most recent award from Forbes who
-
of Wisconsin School of Medicine and Public Health. Of the 16 faculty, five affiliate faculty, and emeritus faculty, several have been recognized with national and international honors, including by the National
-
RNA therapeutics for treating disease. Current projects involve mRNA and antisense oligonucleotide approaches for treating lysosomal storage disease, Usher syndrome, cystic fibrosis, as
-
investigating RNA therapeutic approaches for genetic disease. The current focus of the project is on mRNA and antisense oligonucleotide drug discovery for treating lysosomal storage diseases. The lab uses cell